Target intelligence / Profile preview

Myosin, light chain 12-like, regulatory pseudogene

Molecular classification
Pseudogene, Transcribed Pseudogene
01

Overview

The "myosin, light chain 12-like, regulatory pseudogene" is a non-protein-coding pseudogene related to the myosin light chain family. Unlike canonical myosin light chain proteins (such as MYL12A or MYL12B), this pseudogene does not produce a functional regulatory light chain subunit and does not directly participate in myosin-mediated contractile mechanics. Some myosin light chain-related pseudogenes can act in gene regulation by affecting the RNA stability or transcription of their parental genes, potentially impacting cellular processes such as proliferation. However, no evidence supports a direct therapeutic or biomarker role for this specific pseudogene (ENSG00000263199). Pseudogenes may sometimes be misclassified as protein-coding targets in large genomic datasets; careful curation is required to avoid such errors when selecting drug targets[2][4]. In summary, ENSG00000263199 represents a regulatory pseudogene, not a canonical therapeutic target[2][4]. If your intent is to study a druggable myosin light chain protein, targets such as MYL12A or MYL12B (protein-coding genes) should be used instead[6].

Other names
MYL12-like pseudogeneMYL12 pseudogenemyosin regulatory light chain 12-like pseudogene
02

Biological functions

Possible regulatory RNA function
03

Disease associations

No direct association; by analogy, similar pseudogenes are implicated in cancer regulation

Beyond the preview

Go deeper on Myosin, light chain 12-like, regulatory pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin, light chain 12-like, regulatory pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call